Aromatic Retinoid in the Chemoprevention of the Progression of Nevoid Basal‐Cell Carcinoma Syndrome

Abstract

The management of nevoid basal-cell carcinomas in this syndrome is sometimes very difficult, because of the high number of tumors and of their particular localizations. The authors reviewed the literature and here report their experience in the treatment of nevoid basal-cell carcinoma syndrome with aromatic retinoid etretinate (RO 10-9359; Tigason).